ROSE Cluster 1
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Early Rebiopsy to Identify Biomarkers of Tumor Cell Survival Following EGFR, ALK, ROS1 or BRAF TKI Therapy (NCT03042221) | University of Colorado, Denver | 2016-05-10 |
Track ROSE Cluster 1 automatically
Every clearance here is in the API, with alerts when new ones post.